Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio
Clinical trial NCT06570772 · TERMINATED
Trial details
- NCT number
- NCT06570772
- Sponsor
- Alvotech Swiss AG
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-23
- Primary completion
- 2025-11-25
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.